Annovis Bio Inc (NYSE: ANVS) kicked off on Monday, up 7.92% from the previous trading day, before settling in for the closing price of $3.79. Over the past 52 weeks, ANVS has traded in a range of $1.11-$7.52.
Annual sales at Healthcare sector company slipped by -73.95% over the past five years. While this was happening, its average annual earnings per share was recorded 42.00%. With a float of $22.45 million, this company’s outstanding shares have now reached $26.50 million.
Annovis Bio Inc (ANVS) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Annovis Bio Inc is 15.28%, while institutional ownership is 11.40%. The most recent insider transaction that took place on Nov 21 ’25, was worth 69,900. In this transaction Director of this company bought 20,000 shares at a rate of $3.50, taking the stock ownership to the 2,490,539 shares. Before that another transaction happened on Nov 14 ’25, when Company’s Director bought 15,000 for $2.11, making the entire transaction worth $31,650. This insider now owns 2,470,539 shares in total.
Annovis Bio Inc (ANVS) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 42.00% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 18.51% during the next five years compared to -73.95% drop over the previous five years of trading.
Annovis Bio Inc (NYSE: ANVS) Trading Performance Indicators
Take a look at Annovis Bio Inc’s (ANVS) current performance indicators. Last quarter, stock had a quick ratio of 4.60.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.48, a number that is poised to hit -0.34 in the next quarter and is forecasted to reach -1.40 in one year’s time.
Technical Analysis of Annovis Bio Inc (ANVS)
Annovis Bio Inc (NYSE: ANVS) saw its 5-day average volume 3.7 million, a positive change from its year-to-date volume of 0.77 million. As of the previous 9 days, the stock’s Stochastic %D was 89.12%.
During the past 100 days, Annovis Bio Inc’s (ANVS) raw stochastic average was set at 86.60%, which indicates a significant increase from 84.88% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.46 in the past 14 days, which was higher than the 0.21 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.29, while its 200-day Moving Average is $2.20. Nevertheless, the first resistance level for the watch stands at $4.44 in the near term. At $4.79, the stock is likely to face the second major resistance level. The third major resistance level sits at $5.10. If the price goes on to break the first support level at $3.78, it is likely to go to the next support level at $3.47. The third support level lies at $3.12 if the price breaches the second support level.
Annovis Bio Inc (NYSE: ANVS) Key Stats
The company with the Market Capitalisation of 108.40 million has total of 26,503K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -24,590 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -7,260 K.
